Insmed revenue and financials

INSM · NASDAQ · USD

$105.23Change from previous close: +1.35%Absolute change: +$1.40

Close · October 6, 2026

In the fiscal year ended December 2025, Insmed reported revenue of $606.42M (+66.73% year over year). The net loss was $1.28B.

Annual revenue · 2025: $606.42M
  1. $9.84M2018
  2. $136.47M2019
  3. $164.41M2020
  4. $188.46M2021
  5. $245.36M2022
  6. $305.21M2023
  7. $363.71M2024
  8. $606.42M2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+66.73%
2025 vs 2024
Net margin
-210.5%
2024: -251.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets2,1032,0762,2652,3612,4801,8032,0252,0531,8101,1591,3301,325
Current assets1,6341,6131,7941,9322,0821,4031,6221,6501,418759929927
Cash and equivalents5455825103351,2844035554611,247596482487
Short-term investments6166419201,3455727968791,006——298299
Receivables21517914165.355.047.752.042.340.337.241.235.6
Inventory14213313212110810198.698.590.183.083.277.9
Net property, plant and equipment210204139117117117116110109106104105
Goodwill136136136136136136136136136136136136
Other intangible assets72.973.774.660.330.730.730.830.830.930.931.031.0
Current liabilities439361469417312239298259524421226197
Accounts payable74.673.479.979.674.157.773.065.051.444.065.465.4
Long-term debt7037047047047021,2681,2641,1151,1051,0961,3101,301
Total debt580580587576576———————
Total liabilities1,3451,3711,5261,4151,2301,7041,7401,5701,7711,6241,6621,614
Total equity (incl. minority)7577057399461,25099.228548338.8-465-332-289
Retained earnings-5,813-5,800-5,637-5,308-4,938-4,617-4,360-4,124-3,904-3,603-3,446-3,260